Folate deficiency affects histone methylation

Medical Hypotheses

Volumn 88, Issue , 2016, Pages 63-67

  Garcia, Benjamin A ^a   Luka, Zigmund ^b   Loukachevitch, Lioudmila V ^b   Bhanu, Natarajan V ^a   Wagner, Conrad ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLGLYCINE DEHYDROGENASE; HISTONE DEMETHYLASE; HISTONE H3; LYSINE DEMETHYLASE 1; SARCOSINE DEHYDROGENASE; TETRAHYDROFOLIC ACID; UNCLASSIFIED DRUG; 5,6,7,8-TETRAHYDROFOLIC ACID; FOLIC ACID; HISTONE; LYSINE; TETRAHYDROFOLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; FOLIC ACID DEFICIENCY; GENE EXPRESSION; HISTONE METHYLATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PILOT STUDY; PROTEIN PROCESSING; WESTERN BLOTTING; CHEMISTRY; DNA METHYLATION; ENZYME ACTIVE SITE; ESCHERICHIA COLI; GENETIC EPIGENESIS; HUMAN; IMMUNOLOGY; METABOLISM; THEORETICAL MODEL;

CATALYTIC DOMAIN; DNA METHYLATION; EPIGENESIS, GENETIC; ESCHERICHIA COLI; FOLIC ACID; FOLIC ACID DEFICIENCY; HISTONE DEMETHYLASES; HISTONES; HUMANS; LYSINE; MASS SPECTROMETRY; MODELS, THEORETICAL; PILOT PROJECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SARCOSINE DEHYDROGENASE; TETRAHYDROFOLATES;

EID: 84958174087     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.12.027     Document Type: Article

References (28)

1. Bhaumik S.R., Smith E., Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 2007, 14:1008-1016.
2. Holbert M.A., Marmorstein R. Structure and activity of enzymes that remove histone modifications. Curr Opin Struct Biol 2005, 15:673-680.
3. Mosammaparast N., Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010, 79:155-179.
4. Greer E.L., Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012, 13:343-357.
5. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
6. Forneris F., Binda C., Vanoni M.A., Mattevi A., Battaglioli E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett 2005, 579:2203-2207.
7. Anand R., Marmorstein R. Structure and mechanism of lysine-specific demethylase enzymes. J Biol Chem 2007, 282:35425-35429.
8. Gubisne-Haberle D., Hill W., Kazachkov M., Richardson J.S., Yu P.H. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 2004, 310:1125-1132.
9. Wittwer A.J., Wagner C. Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase. Proc Natl Acad Sci USA 1980, 77:4484-4488.
10. Wittwer A.J., Wagner C. Identification of the folate-binding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Purification and folate-binding characteristics. J Biol Chem 1981, 256:4102-4108.
11. Wittwer A.J., Wagner C. Identification of the folate-binding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Flavoprotein nature and enzymatic properties of the purified proteins. J Biol Chem 1981, 256:4109-4115.
12. Blakley R.L. Spectrophotometric studies on the combination of formaldehyde with tetrahydropteroylglutamic acid and other hydropteridines. Biochem J 1960, 74:71-82.
13. Abeles R.H., Mackenzie C.G. Production of active formaldehyde in the mitochondrial oxidation of sarcosine-CD3. J Biol Chem 1956, 222:145-150.
14. Luka Z., Moss F., Loukachevitch L.V., Bornhop D.J., Wagner C. Histone demethylase LSD1 is a folate-binding protein. Biochemistry 2011, 50:4750-4756.
15. Luka Z., Pakhomova S., Loukachevitch L.V., Calcutt M.W., Newcomer M.E., Wagner C. Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate. Protein Sci 2014, 23:993-998.
16. Steenkamp D.J., Husain M. The effect of tetrahydrofolate on the reduction of electron transfer flavoprotein by sarcosine and dimethylglycine dehydrogenases. Biochem J 1982, 203:707-715.
17. Bills N.D., Koury M.J., Clifford A.J., Dessypris E.N. Ineffective hematopoiesis in folate-deficient mice. Blood 1992, 79:2273-2280.
18. Lin S., Garcia B.A. Examining histone posttranslational modification patterns by high-resolution mass spectrometry. Methods Enzymol 2012, 512:3-28.
19. Yuan Z.F., Lin S., Molden R.C., Cao X.J., Bhanu N.V., Wang X., et al. EpiProfile quantifies histone peptides with modifications by extracting retention time and intensity in high-resolution mass spectra. Mol Cell Proteomics 2015, 14:1696-1707.
20. Nicholson T.B., Chen T. LSD1 demethylates histone and non-histone proteins. Epigenetics 2009, 4:129-132.
21. Zheng Y.C., Ma J., Wang Z., Li J., Jiang B., Zhou W., et al. A systematic review of histone lysine-specific demethylase 1 and its inhibitors. Med Res Rev 2015, 35:1032-1071.
22. Porter D.H., Cook R.J., Wagner C. Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver. Arch Biochem Biophys 1985, 243:396-407.
23. Baron R., Vellore N.A. LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition. Proc Natl Acad Sci USA 2012, 109:12509-12514.
24. Burg J.M., Link J.E., Morgan B.S., Heller F.J., Hargrove A.E., McCafferty D.G. KDM1 class flavin-dependent protein lysine demethylases. Biopolymers 2015, 104:213-246.
25. DeVilbiss E.A., Gardner R.M., Newschaffer C.J., Lee B.K. Maternal folate status as a risk factor for autism spectrum disorders: a review of existing evidence. Br J Nutr 2015, 1-10.
26. Hinterberger M., Fischer P. Folate and Alzheimer: when time matters. J Neural Transm 2013, 120:211-224.
27. Araujo J.R., Martel F., Borges N., Araujo J.M., Keating E. Folates and aging: role in mild cognitive impairment, dementia and depression. Ageing Res Rev 2015, 22:9-19.
28. Lynch J.T., Harris W.J., Somervaille T.C. LSD1 inhibition: a therapeutic strategy in cancer?. Expert Opin Ther Targets 2012, 16:1239-1249.